Interestingly, autoantibodies against aberrantly glycosylated MUC1 have been associated with ovarian cancer, and they have the potential to serve as non-invasive biomarkers for earlier diagnosis of OC [41]. This evidence concerns the gene MUC1 and ovarian carcinoma.